Last $60.11 USD
Change Today +0.11 / 0.18%
Volume 5.7M
MRK On Other Exchanges
Symbol
Exchange
New York
Mexico
EN Paris
Sao Paulo
Frankfurt
As of 8:04 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Elizabeth H. S. Wyatt

AgeTotal Calculated CompensationThis person is connected to 19 board members in 3 different organizations across 9 different industries.

See Board Relationships
66--

Background*

Mrs. Elizabeth H. S. Wyatt served as the Vice President of Corporate Licensing at Merck & Co., Inc. from 1992 to 2000. Mrs. Wyatt has an extensive experience in corporate licensing and acquisition with responsibilities including compound and technology acquisition, research collaborations and competitive and licensing information functions. Mrs. Wyatt joined Merck in 1980 and was responsible for many of its major agreements. Previously, she served as a Consultant and ...

Read Full Background

Corporate Headquarters*

One Merck Drive
Whitehouse Station, New Jersey 08889

United States

Phone: 908-423-1000
Fax: --

Board Members Memberships*

Director
Director
Former Non Executive Director
2002-2008
Former Director, Member of Audit Committee and Member of the Executive Committee
2002-N/A
Former Director, Member of Corporate Governance Committee and Member of Scientific Review Committee
2002-Present
Director, Chairman of Investment Committee, Member of Audit Committee and Member of Compliance Committee
2004-2009
Former Non-Executive Director, Member of Audit Committee, Member of Nomination Committee and Member of Remuneration Committee
2005-Present
Lead Director and Chairman of Compensation Committee
2005-2006
Former Non Executive Director

Education*

MS
Boston University
M.Ed
Boston University
BA
Sweet Briar College
MBA
Harvard Business School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRK:US $60.11 USD +0.11

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Christopher A. Viehbacher Chief Executive Officer, Director and Member of Strategy Committee
Sanofi
€3.0M
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
SFr.5.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK & CO. INC., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.